These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 11293181)

  • 1. Management protocols for hepatitis B.
    Agarwal S; Sarin SK
    Indian J Gastroenterol; 2001 Mar; 20 Suppl 1():C52-4. PubMed ID: 11293181
    [No Abstract]   [Full Text] [Related]  

  • 2. Combination therapy with alpha interferon and lamivudine in patients with chronic hepatitis B and HIV infection.
    Nasti G; di Gennaro G; Donada C; Donadon V; Tirelli U
    AIDS; 1999 Oct; 13(15):2176-8. PubMed ID: 10546877
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of hepatitis B virus infection in patients coinfected with HIV.
    Benhamou Y; Bonyhay L
    Gastroenterol Clin North Am; 2004 Sep; 33(3):617-27, x. PubMed ID: 15324947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined interferon and lamivudine therapy: is this the treatment of choice for patients with chronic hepatitis B virus infection?
    Terrault NA
    Hepatology; 2000 Sep; 32(3):675-7. PubMed ID: 10991635
    [No Abstract]   [Full Text] [Related]  

  • 5. Which combination should be preferred in the management of children with chronic hepatitis B infection?
    Dikici B; Ece A; Bosnak M
    J Clin Gastroenterol; 2005 Sep; 39(8):745-6. PubMed ID: 16082291
    [No Abstract]   [Full Text] [Related]  

  • 6. Chronic hepatitis B: interferon-monotherapy or combination with nucleoside analogues?
    Tassopoulos NC
    Liver; 1998 Apr; 18(2):71-2. PubMed ID: 9588765
    [No Abstract]   [Full Text] [Related]  

  • 7. Lamivudine treatment for children with interferon refractory chronic hepatitis B.
    Koçak N; Saltik IN; Ozen H; Yüce ; Gürakan F
    Hepatology; 2000 Feb; 31(2):545. PubMed ID: 10691379
    [No Abstract]   [Full Text] [Related]  

  • 8. Management and treatment of chronic hepatitis B virus: Belgian Association for the Study of the Liver (BASL) 2007 guidelines.
    Colle I; Adler M; Brenard R; Henrion J; Langlet P; Michielsen P; Orlent H; Reynaert H; Sprengers D; Stärkel P; Van Damme P; Verslype C; Delwaide J;
    Acta Gastroenterol Belg; 2007; 70(4):389-420. PubMed ID: 18330099
    [No Abstract]   [Full Text] [Related]  

  • 9. [Chronic hepatitis--new therapeutic options].
    Arnold JC; Stremmel W
    Internist (Berl); 2001 Apr; 42(4):516-22. PubMed ID: 11326734
    [No Abstract]   [Full Text] [Related]  

  • 10. Lamivudine for chronic hepatitis B and HIV co-infection.
    Carton JA; Maradona JA; Asensi V; Rodríguez M; Martínez A
    AIDS; 1999 May; 13(8):1002-3. PubMed ID: 10371189
    [No Abstract]   [Full Text] [Related]  

  • 11. [Chronic hepatitis B virus infection].
    Trifan A; Stanciu C
    Rev Med Chir Soc Med Nat Iasi; 2003; 107(1):19-27. PubMed ID: 14755965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of lamiduvine-resistant mutant chronic hepatitis B with interferon alpha].
    Pariente A; Tachet A; Poveda JD
    Gastroenterol Clin Biol; 2002 Nov; 26(11):1059-60. PubMed ID: 12483147
    [No Abstract]   [Full Text] [Related]  

  • 13. Chronic hepatitis B.
    Lok AS
    N Engl J Med; 2002 May; 346(22):1682-3. PubMed ID: 12037146
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment strategies for viral hepatitis].
    Matsushima T
    Hokkaido Igaku Zasshi; 2002 Mar; 77(2):133-5. PubMed ID: 11968844
    [No Abstract]   [Full Text] [Related]  

  • 15. The management of chronic hepatitis B infection.
    Matthews GV; Nelson MR
    Int J STD AIDS; 2001 Jun; 12(6):353-7. PubMed ID: 11368814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does the addition of lamivudine to peginterferon alpha-2a sustain response rates in HBeAg-negative hepatitis B?
    Cooksley G
    Nat Clin Pract Gastroenterol Hepatol; 2005 Jan; 2(1):12-3. PubMed ID: 16265091
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of chronic hepatitis B virus infection in patients co-infected with human immunodeficiency virus.
    Benhamou Y; Poynard T
    J Hepatol; 2003; 39 Suppl 1():S194-9. PubMed ID: 14708703
    [No Abstract]   [Full Text] [Related]  

  • 18. [Combined polychemotherapy of patients with chronic hepatitis C].
    Nikitin IG; Storozhakov GI; Kuznetsov SL; Strochenovskiĭ AB
    Klin Med (Mosk); 1999; 77(5):24-6. PubMed ID: 10394782
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treating chronic lamivudine-resistant hepatitis B in HIV co-infected patients].
    Benhamou Y
    Gastroenterol Clin Biol; 2006 Oct; 30(10 Pt 2):3S22-5. PubMed ID: 17075492
    [No Abstract]   [Full Text] [Related]  

  • 20. [The first nucleotide analog permitted. New hepatitis B therapy helps the problem patients, too].
    MMW Fortschr Med; 2003 Jun; 145(24):52. PubMed ID: 12866303
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.